{"id":48492,"date":"2023-03-24T01:45:46","date_gmt":"2023-03-24T01:45:46","guid":{"rendered":"https:\/\/dailytalks.org\/?p=48492"},"modified":"2023-03-24T01:45:46","modified_gmt":"2023-03-24T01:45:46","slug":"essex-and-henlius-signed-amendment-agreement-for-global-co-development-and-exclusive-license-agreement-for-treatment-of-age-related-macular-degeneration","status":"publish","type":"post","link":"https:\/\/dailytalks.org\/?p=48492","title":{"rendered":"Essex and Henlius signed amendment agreement for Global Co-Development and Exclusive License Agreement for treatment of age-related macular degeneration"},"content":{"rendered":"<p>HONG KONG, Feb 22, 2023 &#8211; (ACN Newswire) &#8211;  Essex Bio-Technology Ltd (&#8220;Essex&#8221; or the &#8220;Group&#8221;, Stock Code: 1061.HK) today announced that two of its wholly-owned subsidiaries, Essex Bio-Investment Limited (&#8220;Essex Bio-Investment&#8221;) and Zhuhai Essex Bio-Pharmaceutical Co. Ltd (&#8220;Zhuhai Essex&#8221;), signed an amendment agreement (the &#8220;Amendment Agreement&#8221;) with Shanghai Henlius Biotech&#8230;<br \/><a href=\"https:\/\/en.acnnewswire.com\/press-release\/english\/81403\/\" class=\"button purchase\" rel=\"nofollow noopener\" target=\"_blank\">Read More<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>HONG KONG, Feb 22, 2023 &#8211; (ACN Newswire) &#8211; Essex Bio-Technology Ltd (&#8220;Essex&#8221; or the<\/p>\n","protected":false},"author":1,"featured_media":48493,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[35],"tags":[],"class_list":["post-48492","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-tech"],"featured_image_urls":{"full":["https:\/\/dailytalks.org\/wp-content\/uploads\/2023\/03\/48492-essex-and-henlius-signed-amendment-agreement-for-global-co-development-and-exclusive-license-agreement-for-treatment-of-age-related-macular-degeneration.jpg",220,67,false],"thumbnail":["https:\/\/dailytalks.org\/wp-content\/uploads\/2023\/03\/48492-essex-and-henlius-signed-amendment-agreement-for-global-co-development-and-exclusive-license-agreement-for-treatment-of-age-related-macular-degeneration-150x67.jpg",150,67,true],"medium":["https:\/\/dailytalks.org\/wp-content\/uploads\/2023\/03\/48492-essex-and-henlius-signed-amendment-agreement-for-global-co-development-and-exclusive-license-agreement-for-treatment-of-age-related-macular-degeneration.jpg",220,67,false],"medium_large":["https:\/\/dailytalks.org\/wp-content\/uploads\/2023\/03\/48492-essex-and-henlius-signed-amendment-agreement-for-global-co-development-and-exclusive-license-agreement-for-treatment-of-age-related-macular-degeneration.jpg",220,67,false],"large":["https:\/\/dailytalks.org\/wp-content\/uploads\/2023\/03\/48492-essex-and-henlius-signed-amendment-agreement-for-global-co-development-and-exclusive-license-agreement-for-treatment-of-age-related-macular-degeneration.jpg",220,67,false],"1536x1536":["https:\/\/dailytalks.org\/wp-content\/uploads\/2023\/03\/48492-essex-and-henlius-signed-amendment-agreement-for-global-co-development-and-exclusive-license-agreement-for-treatment-of-age-related-macular-degeneration.jpg",220,67,false],"2048x2048":["https:\/\/dailytalks.org\/wp-content\/uploads\/2023\/03\/48492-essex-and-henlius-signed-amendment-agreement-for-global-co-development-and-exclusive-license-agreement-for-treatment-of-age-related-macular-degeneration.jpg",220,67,false],"chromenews-featured":["https:\/\/dailytalks.org\/wp-content\/uploads\/2023\/03\/48492-essex-and-henlius-signed-amendment-agreement-for-global-co-development-and-exclusive-license-agreement-for-treatment-of-age-related-macular-degeneration.jpg",220,67,false],"chromenews-large":["https:\/\/dailytalks.org\/wp-content\/uploads\/2023\/03\/48492-essex-and-henlius-signed-amendment-agreement-for-global-co-development-and-exclusive-license-agreement-for-treatment-of-age-related-macular-degeneration.jpg",220,67,false],"chromenews-medium":["https:\/\/dailytalks.org\/wp-content\/uploads\/2023\/03\/48492-essex-and-henlius-signed-amendment-agreement-for-global-co-development-and-exclusive-license-agreement-for-treatment-of-age-related-macular-degeneration.jpg",220,67,false]},"author_info":{"display_name":"Jonathan Jeriah","author_link":"https:\/\/dailytalks.org\/?author=1"},"category_info":"<a href=\"https:\/\/dailytalks.org\/?cat=35\" rel=\"category\">Tech<\/a>","tag_info":"Tech","comment_count":"0","_links":{"self":[{"href":"https:\/\/dailytalks.org\/index.php?rest_route=\/wp\/v2\/posts\/48492","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/dailytalks.org\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/dailytalks.org\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/dailytalks.org\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/dailytalks.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=48492"}],"version-history":[{"count":0,"href":"https:\/\/dailytalks.org\/index.php?rest_route=\/wp\/v2\/posts\/48492\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/dailytalks.org\/index.php?rest_route=\/wp\/v2\/media\/48493"}],"wp:attachment":[{"href":"https:\/\/dailytalks.org\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=48492"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/dailytalks.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=48492"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/dailytalks.org\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=48492"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}